These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38260608)

  • 1. Plural molecular and cellular mechanisms of pore domain
    Abreo TJ; Thompson EC; Madabushi A; Soh H; Varghese N; Vanoye CG; Springer K; Park KL; Johnson J; Sims S; Ji Z; Chavez AG; Jankovic MJ; Habte B; Zuberi AR; Lutz C; Wang Z; Krishnan V; Dudler L; Einsele-Scholz S; Noebels JL; George AL; Maheshwari A; Tzingounis AV; Cooper EC
    bioRxiv; 2024 Jun; ():. PubMed ID: 38260608
    [No Abstract]   [Full Text] [Related]  

  • 2. KCNQ2/3 Gain-of-Function Variants and Cell Excitability: Differential Effects in CA1 versus L2/3 Pyramidal Neurons.
    Varghese N; Moscoso B; Chavez A; Springer K; Ortiz E; Soh H; Santaniello S; Maheshwari A; Tzingounis AV
    J Neurosci; 2023 Sep; 43(38):6479-6494. PubMed ID: 37607817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-limited alterations in cortical activity of a knock-in mouse model of KCNQ2-related developmental and epileptic encephalopathy.
    Biba-Maazou N; Becq H; Pallesi-Pocachard E; Sarno S; Granjeaud S; Montheil A; Kurz M; Villard L; Milh M; Santini PL; Aniksztejn L
    J Physiol; 2022 May; 600(10):2429-2460. PubMed ID: 35389519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flexible Stoichiometry: Implications for KCNQ2- and KCNQ3-Associated Neurodevelopmental Disorders.
    Springer K; Varghese N; Tzingounis AV
    Dev Neurosci; 2021; 43(3-4):191-200. PubMed ID: 33794528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.
    Singh NA; Otto JF; Dahle EJ; Pappas C; Leslie JD; Vilaythong A; Noebels JL; White HS; Wilcox KS; Leppert MF
    J Physiol; 2008 Jul; 586(14):3405-23. PubMed ID: 18483067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant.
    Millichap JJ; Miceli F; De Maria M; Keator C; Joshi N; Tran B; Soldovieri MV; Ambrosino P; Shashi V; Mikati MA; Cooper EC; Taglialatela M
    Epilepsia; 2017 Jan; 58(1):e10-e15. PubMed ID: 27861786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Personalized treatment with retigabine for pharmacoresistant epilepsy arising from a pathogenic variant in the KCNQ2 selectivity filter.
    Nissenkorn A; Kornilov P; Peretz A; Blumkin L; Heimer G; Ben-Zeev B; Attali B
    Epileptic Disord; 2021 Oct; 23(5):695-705. PubMed ID: 34519644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditional deletions of epilepsy-associated KCNQ2 and KCNQ3 channels from cerebral cortex cause differential effects on neuronal excitability.
    Soh H; Pant R; LoTurco JJ; Tzingounis AV
    J Neurosci; 2014 Apr; 34(15):5311-21. PubMed ID: 24719109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel homozygous KCNQ3 loss-of-function variant causes non-syndromic intellectual disability and neonatal-onset pharmacodependent epilepsy.
    Lauritano A; Moutton S; Longobardi E; Tran Mau-Them F; Laudati G; Nappi P; Soldovieri MV; Ambrosino P; Cataldi M; Jouan T; Lehalle D; Maurey H; Philippe C; Miceli F; Vitobello A; Taglialatela M
    Epilepsia Open; 2019 Sep; 4(3):464-475. PubMed ID: 31440727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heteromeric Assembly of Truncated Neuronal Kv7 Channels: Implications for Neurologic Disease and Pharmacotherapy.
    Li J; Maghera J; Lamothe SM; Marco EJ; Kurata HT
    Mol Pharmacol; 2020 Sep; 98(3):192-202. PubMed ID: 32580997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. M channel KCNQ2 subunits are localized to key sites for control of neuronal network oscillations and synchronization in mouse brain.
    Cooper EC; Harrington E; Jan YN; Jan LY
    J Neurosci; 2001 Dec; 21(24):9529-40. PubMed ID: 11739564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characteristics of KCNQ2 variants causing either benign neonatal epilepsy or developmental and epileptic encephalopathy.
    Goto A; Ishii A; Shibata M; Ihara Y; Cooper EC; Hirose S
    Epilepsia; 2019 Sep; 60(9):1870-1880. PubMed ID: 31418850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional characterization and in vitro pharmacological rescue of KCNQ2 pore mutations associated with epileptic encephalopathy.
    Yang GM; Tian FY; Shen YW; Yang CY; Yuan H; Li P; Gao ZB
    Acta Pharmacol Sin; 2023 Aug; 44(8):1589-1599. PubMed ID: 36932231
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A.
    Soldovieri MV; Boutry-Kryza N; Milh M; Doummar D; Heron B; Bourel E; Ambrosino P; Miceli F; De Maria M; Dorison N; Auvin S; Echenne B; Oertel J; Riquet A; Lambert L; Gerard M; Roubergue A; Calender A; Mignot C; Taglialatela M; Lesca G
    Hum Mutat; 2014 Mar; 35(3):356-67. PubMed ID: 24375629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of M-channel subunits KCNQ2 and KCNQ3 in rat hippocampus.
    Klinger F; Gould G; Boehm S; Shapiro MS
    Neuroimage; 2011 Oct; 58(3):761-9. PubMed ID: 21787867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of subunit co-assembly and ankyrin-G for M-channel localization at the axon initial segment.
    Rasmussen HB; Frøkjaer-Jensen C; Jensen CS; Jensen HS; Jørgensen NK; Misonou H; Trimmer JS; Olesen SP; Schmitt N
    J Cell Sci; 2007 Mar; 120(Pt 6):953-63. PubMed ID: 17311847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of KCNQ2 or KCNQ3 Leads to Multifocal Time-Varying Activity in the Neonatal Forebrain
    Hou B; Varghese N; Soh H; Santaniello S; Tzingounis AV
    eNeuro; 2021; 8(3):. PubMed ID: 33863780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased subunit stability as a novel mechanism for potassium current impairment by a KCNQ2 C terminus mutation causing benign familial neonatal convulsions.
    Soldovieri MV; Castaldo P; Iodice L; Miceli F; Barrese V; Bellini G; Miraglia del Giudice E; Pascotto A; Bonatti S; Annunziato L; Taglialatela M
    J Biol Chem; 2006 Jan; 281(1):418-28. PubMed ID: 16260777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional responses of the hippocampus to hyperexcitability depend on directed, neuron-specific KCNQ2 K
    Carver CM; Hastings SD; Cook ME; Shapiro MS
    Hippocampus; 2020 May; 30(5):435-455. PubMed ID: 31621989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCNQ2 R144 variants cause neurodevelopmental disability with language impairment and autistic features without neonatal seizures through a gain-of-function mechanism.
    Miceli F; Millevert C; Soldovieri MV; Mosca I; Ambrosino P; Carotenuto L; Schrader D; Lee HK; Riviello J; Hong W; Risen S; Emrick L; Amin H; Ville D; Edery P; de Bellescize J; Michaud V; Van-Gils J; Goizet C; Willemsen MH; Kleefstra T; Møller RS; Bayat A; Devinsky O; Sands T; Korenke GC; Kluger G; Mefford HC; Brilstra E; Lesca G; Milh M; Cooper EC; Taglialatela M; Weckhuysen S
    EBioMedicine; 2022 Jul; 81():104130. PubMed ID: 35780567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.